2012 Fiscal Year Final Research Report
Analysis of the β catenin gene abnormality and therapeutic application for oral cancer.
Project/Area Number |
22390388
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Surgical dentistry
|
Research Institution | Sapporo Medical University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
DEHARI Hironari 札幌医科大学, 医学部, 助教 (00381260)
MIYAZAKI Akihiro 札幌医科大学, 医学部, 准教授 (10305237)
OGI Kazuhiro 札幌医科大学, 医学部, 訪問研究員 (40433114)
SASAKI Takanori 札幌医科大学, 医学部, 研究員 (50548732)
NAKAMORI Kenji 札幌医科大学, 医学部, 講師 (60295334)
KOBAYASHI Jyunichi 札幌医科大学, 医学部, 助教 (80404739)
SOGABE Youhei 札幌医科大学, 医学部, 研究員 (50468104)
YAMAMOTO Takashi 札幌医科大学, 医学部, 研究員 (50448594)
SHIMANISHI Makoto 札幌医科大学, 医学部, 研究員 (10516561)
|
Project Period (FY) |
2010 – 2012
|
Keywords | 口腔がん / βカテニン / 低酸素 / 上皮-間葉転換 / GLUT-1 / NF-κB/p65 |
Research Abstract |
Hypoxic regions in solid tumors mediate malignant transformation, cancer cell proliferation, resistance to anti-cancer agents, and enhanced cellular invasion and metastasis. In this study, we found that the wnt/β-catenin pathway activation mediates the acquisition of invasion and metastatic potential in oral squamous cell carcinoma cells. Hypoxia enhances the expression of glucose transporter 1 (GLUT1) and anticancer drug resistance, and activates NF-κB/p65 to trigger cell proliferation.
|
-
-
-
[Journal Article] Highexpression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cellcarcinomas correlates to lymph node metastasis.2013
Author(s)
Michifuri Y, Hirohashi Y, Torigoe T,Miyazaki A, Kobayashi J, Sasaki T, FujinoJ, Asanuma H, Tamura Y, Nakamori K, Hasegawa T, Hiratsuka H, Sato N.
-
Journal Title
Pathol Int.
Volume: 62(10)
Pages: 684-9
DOI
Peer Reviewed
-
-
[Journal Article] Working Group 1 on the 'Guidelines for Clinical and Pathological Studies of Oral Cancer', Scientific Committee, Japan Society for Oral Tumors.General rules for clinical and pathological studies on oral cancer: a synopsis.2012
Author(s)
Izumo T, Kirita T, Ariji E, Ozeki S, Okada N, Okabe S, Okazaki Y, Omura K, Kusama M, Sato T, Shinohara M, Shimozato K, Shintani S, Tanaka Y, Nakayama E, Hayashi T, Miyazaki A, Yagishita H, Yamane M
-
Journal Title
Jpn J Clin Oncol.
Volume: 42
Pages: 1099-109
Peer Reviewed
-
-
[Journal Article] Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer.2011
Author(s)
Miyazaki A, Kobayashi J, Torigoe T, Hirohashi Y, Yamamoto T, Yamaguchi A,Asanuma H, Takahashi A, Michifuri Y, Nakamori K, Nagai I, Sato N, Hiratsuka H.
-
Journal Title
Cancer Sci.
Volume: 102(2)
Pages: 324-9
DOI
Peer Reviewed
-
-
-
[Presentation] Survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer - Phase I clinical trial2012
Author(s)
Akihiro Miyazaki, Junichi Kobayashi, Toshihiko Torigoe, Yoshihiko Hirohashi, Yoshitaka Michifuri, Takanori Sasaki, Junki Fujino, Hiroko Asanuma, Akari Takahashi, Noriyuki Sato, Hiroyoshi Hiratsuka.
Organizer
日本癌学会総会
Place of Presentation
札幌
Year and Date
20120900
-
-
-
-
-
[Presentation] Small proline-rich protein-1B (SPRP1B) is overexpressed in ALDEFLUOR bright human cancer stem-like oral squamous cell carcinoma and related to its maintenance.2011
Author(s)
Yoshitaka Michifuri, Yoshihiko Hirohashi, Toshihiko Torigoe, Akihiro Miyazaki, Junichi Kobayashi, Takashi Yamamoto, Yasuaki Tamura, Akari Takahashi, Kenji Nakamori, Akira Yamaguchi, Hiroyoshi Hiratsuka, Noriyuki Sato
Organizer
日本癌学会総会
Place of Presentation
名古屋
Year and Date
20111000
-
-
-
-
-
-
-
-
-